Founded in 2015, Adiuvo Diagnostics operates in Enterprise Tech industry. Initially focusing on developing a device that employs multimodal imaging for early detection of skin and soft tissue infectio...
Funding stage:
Seed
Last funding:
17/12/2018
Investors
Employee count:
30
Last 90d
30
Last 90d
Web traffic:
638
638
Last 30d
Last 30d
Glassdoor Rating:
Adiuvo Diagnostics: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders5
Latest Filing Date30 March 2020- Funding Events9
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Adiuvo Diagnostics
As of 31 March 2020, Adiuvo Diagnostics's equity is held by 4 shareholders, with the top three being Menterra Social Impact Fund I, Geethanjali Radhakrishnan, and Lesing Artha Limited.
Menterra Social Impact Fund I holds the largest stake in Adiuvo Diagnostics at 37.9% as of 31 March 2020.
As of 31 March 2020, founders collectively hold 41.1% equity in Adiuvo Diagnostics.
As of 31 March 2020, investors collectively hold 48.6% equity in Adiuvo Diagnostics.
Adiuvo Diagnostics's ESOP pool stands at 10.3% of total equity as of 31 March 2020.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links